This aberrant signaling subsequently triggers the downstream activation of the PI3K-AKT, JAK-STAT, and RAF-MEK-ERK cascades, ultimately promoting the transcriptional upregulation of genes involved in pathological cell proliferation—a hallmark of polycythemia vera, essential thrombocythemia, and PMF (19). The gene discussed is MAP2K7; the disease is essential thrombocythemia.